Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRX



    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of
                 Investors of Trius Therapeutics, Inc. - TSRX

PR Newswire

NEW YORK, July 31, 2013

NEW YORK, July 31, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom &
Gross LLP is investigating claims on behalf of investors of Trius
Therapeutics, Inc. ("Trius" or the "Company") (NASDAQ: TSRX) (ISIN:
US89685K1007) (CUSIP: 89685K100) concerning the proposed acquisition of Trius
by Cubist Pharmaceuticals, Inc. in a transaction valued at $818 million.

The investigation concerns whether the Trius directors are breaching their
fiduciary duties by failing to adequately shop the Company and maximize
shareholder value.  Under the terms of the agreement, Trius shareholders will
be entitled to receive $13.50 per share in cash for each share of Trius common
stock. In addition to the upfront cash payment, each Trius stockholder will
receive one Contingent Value Right, entitling the holder to receive an
additional cash payment of up to $2.00 for each share they own if certain
commercial sales milestones are achieved.  However, the price to Revenue and
Book Value multiples are below the averages of comparable transactions and at
least one analyst has set a target price of $20.00 per share for Trius common
stock.

Trius shareholders seeking more information about this acquisition are advised
to contact Robert Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or
888-476-6529, ext. 237.

The firm is also investigating actions on behalf of shareholders for the
following companies:  Hilltop Community Bancorp, Inc., Dole Food Company,
Inc., and Cooper Tire & Rubber Company.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego,
is acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the Pomerantz Firm
pioneered the field of securities class actions. Today, more than 75 years
later, the Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of fiduciary duty,
and corporate misconduct. The Firm has recovered numerous multimillion-dollar
damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

CONTACT:
Robert Willoughby
Pomerantz Grossman Hufford Dahlstrom & Gross LLP
212-661-1100 ext. 237
rswilloughby@pomlaw.com

SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Website: http://www.pomerantzlaw.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement